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1. Introduction
“Complication, in medicine, is an unfavorable evolution of a disease, a health condition or a therapy.
The disease can become worse in its severity or show a higher number of signs, symptoms, or new
pathological changes, become widespread throughout the body or affect other organ systems. A new
disease may also appear as a complication to a previous existing disease. A medical treatment, such as
drugs or surgery may produce adverse effects and/or produce new health problem(s) by itself. There‐
fore, a complication may be iatrogenic, i.e., literally brought forth by the physician. Medical knowl‐
edge about a disease, procedure or treatment usually entails a list of the most common complications,
so that they can be foreseen, prevented or recognized more easily and speedily.
Depending on the degree of vulnerability, susceptibility, age, health status, immune system condition,
etc. complications may arise more easily. Complications affect adversely the prognosis of a disease.
Non-invasive and minimally invasive medical procedures usually favor fewer complications in com‐
parison to invasive ones.” [1]
A currently popular focus in the gastroenterology and endoscopic literature is the quality of
colonoscopy with regard to colorectal cancer screening [2]. This includes the collection of
evidence regarding the use of colonoscopy as a tool for screening programs, defining and
establishing quality indicators and minimum requirements that endoscopists involved in
colorectal cancer screening programs should meet, and providing evidence about proce‐
dures that may improve the quality of colonoscopy. Those who have decades of experience
performing colonoscopy will be quite familiar with the myriad of complications associated
with the procedure, either through their reading of the gastrointestinal endoscopy literature,
from personal experience or the experience of colleagues. That being said, three major cate‐
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gories of complications associated with colonoscopy are widely recognized. They are seda‐
tion-related complications, hemorrhage associated with colonic polypectomy and
colonoscopy-related colonic perforation. Sedation-related complications are usually cardio‐
vascular and/or pulmonary and include oxygen desaturation, respiratory arrest, alterations
in heart rate (bradycardia and tachycardia), cardiac arrhythmias, myocardial infarction,
stroke, seizures (at times attributed to the method of preparation) and shock. Hemorrhage is
most often associated with snare electrocautery polypectomy but may also occur during the
performance of diagnostic colonoscopy with or without biopsies. Two general subcategories
of hemorrhage exist: hemorrhage immediately following the performance of polypectomy
or delayed hemorrhage occurring up to several weeks after the therapeutic procedure. Co‐
lonic perforation resulting from colonoscopy may occur due to mechanical forces exerted
against the colonic wall (colonoscope tip or shaft, biopsy forceps, dilatation of a stricture),
barotrauma as a result of intraluminal air or carbon dioxide insufflation, or as a result of a
therapeutic procedure such as polypectomy, foreign body extraction, or stent placement to
name a few. A thorough understanding of these complications, their incidence and treat‐
ment, is part of the training of all those learning to perform colonoscopy and forms the basis
for the physician obtaining informed consent (an explanation of the risks and benefits of the
procedure) from the patient. This chapter will systematically review our current under‐
standing of these complication categories and the methods of minimizing the likelihood of
developing these complications. The latest treatments of specific complications will be re‐
viewed with the intent of aiding the physician endoscopist’s understanding of the principles
of risk management as regards to performing colonoscopy.
“Primum non nocere” is the Latin phrase that means "First, do no harm". Non-maleficence,
which is derived from this maxim, is one of the principal precepts of medical ethics taught
to all medical students in medical school and is a fundamental principle for the provision of
medical services world-wide. Another way to state it is that "given an existing problem, it
may be better not to do something, or even to do nothing, than to risk causing more harm
than good." It reminds the physician and other health care providers that they must consid‐
er the possible harm that any intervention might do. It is invoked when debating the use of
an intervention that carries an obvious risk of harm but a less certain chance of benefit. This
ancient principle should be kept in mind when contemplating colonoscopy and the possible
complications of the procedure.
1.1. Informed consent for colonoscopy
The doctrine of informed consent (and its antithesis, informed refusal) for colonoscopy in‐
volves an assessment of the competence of the patient by the physician, disclosure of, in an
understandable way, the information necessary to allow the patient to make an informed
decision (risks and benefits considered) regarding the role of colonoscopy in his care, and
the documentation of these proceedings in the medical record [3]. It is an intrinsic part of the
doctor-patient relationship and an ethical obligation on the part of the physician in the clini‐
cal practice of medicine. In the United States, the doctrine of medical informed consent is
most famously traced back to a 1914 New York court decision centered about the observa‐
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tion that since most surgical operations involve some use of force, there must be consent on
the part of the patient. Because the nature of surgery is outside the experience of most pa‐
tients, the consent must be granted only after the patient is properly informed of the risks
and benefits. The most famous description of informed consent is a quote from New York
Justice Benjamin Cardozo who, in 1914, stated that:
"Every human being of adult years and sound mind has a right to determine what shall be done with
his own body; and a surgeon who performs an operation without his patient's consent commits an
assault for which he is liable in damages" [4]. 
This advice is still applicable in the 21st century! Most important in considering the compli‐
cations of colonoscopy is the need to meticulously document the obtaining of informed con‐
sent from the patient and the procedural technique, findings and outcome including any
complications [5].
2. Sedation-related complications of colonoscopy
Sedation-related complications of colonoscopy are usually cardiovascular, pulmonary and oc‐
casionally neurological. The risk of these events occurring is associated with advancing age,
higher American Society of Anesthesiologists Physical Status Classification System scores
(ASA score—with category 6 not being applicable), and the patient’s co-morbidities [6-8].
ASA Physical Status Classification System (I-VI)
ASA-I A normal healthy patient.
ASA-II A patient with mild systemic disease.
ASA-III A patient with severe systemic disease.
ASA-IV A patient with severe systemic disease that is a constant threat to life.
ASA-V A moribund patient who is not expected to survive without the operation.
ASA-VI A declared brain-dead patient whose organs are being removed for donor purposes.
ASA-E Emergency operation of any variety (used to modify one of the above classifications,
i.e., ASA III-E)
In general, patients’ inpatient status, trainee participation and the routine use of supplemen‐
tal oxygen (the latter by possibly masking hypercapnea and hypoventilation) are associated
with a higher risk of unplanned cardiopulmonary events [9]. The monitoring period for the
“event rate” should likely include the 30 days post procedure [10].
2.1. Hypoxemia
Hypoxemia, which is usually transient but often anxiety provoking for the colonoscopist, is
a common occurrence during sedation for colonoscopy and has lead to the often “routine”
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practice by colonoscopists and attending anesthesiologists and nurse anesthetists of provid‐
ing patients with supplemental oxygen [9] delivered by nasal cannula and on occasion by a
venturi air-entrapment mask (the latter providing a fixed and predictable oxygen concentra‐
tion despite a variable respiration pattern). Prolonged hypoxemia associated with colono‐
scopy is rare. The etiology of hypoxemia is often multifactorial but not to be overlooked is
the amount of air (or carbon dioxide) insufflated into the colon for adequate luminal disten‐
tion and in some cases the passing of this gas into the small bowel through an incompetent
ileocecal valve thereby affecting diaphragmatic function. This has lead most endoscopists to
periodically monitor the degree of abdominal distention (“softness”) by direct palpation of
the abdomen either routinely during the procedure or when there are drops in the moni‐
tored oxygen saturation.
2.2. Hypercapnea
Capnography monitor use is widespread in hospitals but these devices are less commonly
used in the gastrointestinal endoscopy suite and other ambulatory settings where propofol
is often used. In 2012 the American Society of Anesthesiologists (ASA) advised its member
to use such carbon dioxide monitoring devices that detect changes in the amount of carbon
dioxide the patient is exhaling during monitored anesthesia care for upper gastrointestinal
endoscopies [11]. The new policy states:
“Monitoring for exhaled carbon dioxide should be considered during endoscopic procedures in which
sedation is provided with propofol alone or in combination with opioids and/or benzodiazepines, and
especially during these procedures on the upper gastrointestinal tract. Careful attention to airway
management must be provided during endoscopic retrograde cholangiopancreatography (ERCP) pro‐
cedures performed in the prone position where ventilatory monitoring, airway maintenance and re‐
suscitation may be especially difficult.”
It has only been a matter of time since this recommendation has found application in the
monitoring of sedated patients undergoing colonoscopy. The new policy has met with
mixed reviews in the gastrointestinal endoscopy and anesthesiology communities but most
have agreed that there is little downside to such monitoring.
It is important to emphasize that at least one individual with training in advanced cardiac
life support (tracheal intubation, defibrillation, use of resuscitation medications, ACLS cer‐
tification) that is capable of establishing an airway and providing positive-pressure ventila‐
tion should be present during colonoscopy sedation. Ability for communication with “back
up” local paramedics or life support personnel should be confirmed.
2.3. Hypotension
The etiology of hypotension during colonoscopy is also multifactorial (pre-procedure anti‐
hypertensive medications, sedatives and analgesics used during the performance of the pro‐
cedure, arrhythmias, pre-procedure cardiac performance status, etc.) but the state of
hydration of the patient after (usually a polyethylene glycol containing) bowel preparation
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may reign supreme among the factors to consider. Intravenous replacement with crystalloid
solutions should be considered during such events and in anticipation of such events in ap‐
propriately screened patients.
2.4. Arrhythmia
Cardiac arrhythmias including bradycardia, less often tachycardia, atrial premature contrac‐
tions, paroxysms of atrial fibrillation, and ventricular premature contractions have been
documented during procedural sedation. Most resolve with the intravenous administration
of fluids or increased sedation. With regard to bradycardia there is asymptomatic bradycar‐
dia (heart rate less than 60 bpm) and symptomatic bradycardia defined as a heart rate less
than 60/min that elicits signs and symptoms. In symptomatic bradycardia the heart rate will
usually be less than 50/min. Symptomatic bradycardia exists when the following 3 criteria
are present: 1.) The heart rate is slow; 2.) The patient has symptoms; and 3.) The symptoms
are due to the slow heart rate. Atropine is the first drug of choice for symptomatic bradycar‐
dia [12]. The dose in the bradycardia ACLS algorithm is 0.5 mg IV push which may be re‐
peated up to a total dose of 3 mg. (Anesthesiologists often choose glycopyrrolate [Robinul®]
as an alternative to atropine.) Dopamine is a second line drug for symptomatic bradycardia
when atropine is not effective. The dosage is 2-10 micrograms/kg/min infusion. Epinephrine
can be used as an equal alternative to dopamine when atropine is not effective. The dosage
is 2-10 micrograms/min. Rare cases of ventricular tachycardia and cardiac arrest during ven‐
tricular fibrillation have been reported necessitating the need for continuous EKG monitor‐
ing, the availability of ACLS trained personnel, as well as obtaining a history of cardiac or
pulmonary disease prior to initiating the procedure.
2.5. Pulmonary embolism
Although the prevalence of coexistent pulmonary embolism at the time of colon cancer de‐
tection has been estimated to be as high as 2% (with the concurrent prevalence of deep ve‐
nous thrombosis being as high as 8%) there are no accepted statistics for the incidence of
pulmonary embolism complicating diagnostic or therapeutic colonoscopy [13].
2.6. TIA/stroke
The risk of stroke in patients with AF whose anticoagulation is adjusted for endoscopies is
low, but almost tenfold higher in patients with complex clinical situations [14]. Age, history
of stroke, hypertension, hyperlipidemia, and family history of vascular disease may increase
the risk of suffering a stroke during or immediately after undergoing a gastrointestinal en‐
doscopic procedure. Comprehensive guidelines for the management of anticoagulation and
antiplatelet therapy in patients undergoing gastrointestinal endoscopic procedures includ‐
ing colonoscopy have recently been published [15] and should serve as a reference and
guide when dealing with such patients.




Recent myocardial infarction has traditionally precluded the performance of elective colono‐
scopy for at least several months but recently this issue has been closely addressed in the
literature [16]. Colonoscopy performed in patients who have experienced a recent myocar‐
dial infarction is associated with a higher rate of minor, transient, and primarily cardiovas‐
cular complications when compared with control patients but is relatively infrequently
associated with major complications. In certain circumstances, despite the higher risk, colo‐
noscopy may be beneficial in this setting, particularly given the higher frequency of ische‐
mic colitis in this patient population. The occurrence of cardiac ischemia (and concomitant
cardiac rhythm disturbances) in patients undergoing colonoscopy who have known cardiac
disease or cardiac risk factors has recently been quantified [17]. Holter EKG recordings and
measurement of cTnI troponin I levels showed a high incidence of new but silent ischemic
and arrhythmic EKG changes during colonoscopy and do a lesser extent those patients with
one or more risk factors for heart disease. Two patients with known heart disease died with‐
in 30 days of colonoscopy.
3. Colonic hemorrhage associated with polypectomy
Although hemorrhage can occur during diagnostic colonoscopy (particularly when “cold”
or “hot” forceps biopsy techniques are used) it most often complicates polypectomy occur‐
ring immediately or being delayed for several weeks after the procedure [18]. The overall
incidence of hemorrhage has been reported to be in the range of 1 to 6 per 1,000 colonoscop‐
ies [19,6] (this being a useful figure to quote when obtaining informed consent from the pa‐
tient) with the number of polyps [20], polyp size [19] recent anticoagulant use [22,23] and
even polyp histology(!) [6,24,25] being modifying factors! The effects of aspirin, nonsteroidal
anti-inflammatory drugs and clopidogrel both alone and in combination on this complica‐
tion of colonoscopy have also been addressed [26,27].
Patients requiring colonoscopy with or without biopsy and/or polypectomy are often taking
antithrombotic agents including anticoagulants such as warfarin, heparin, and low molecular
weight  heparin,  and antiplatelet  agents  such as  aspirin,  non-steroidal  anti-inflammatory
drugs, thienopyridines such as clopidrogel and ticlopidine, and glycoprotein IIb/IIIa receptor
inhibitors. The indications for the use of these medications include atrial fibrillation, acute cor‐
onary syndrome, deep venous thrombosis, hypercoagulable states and indwelling endopros‐
theses such as coronary artery stents. When hemorrhage does occur in patients taking these
agents it is most commonly from the gastrointestinal tract [28]. Risk stratification for these pa‐
tients can generally be relegated to two categories. Low risk procedures include diagnostic co‐
lonoscopy including mucosal biopsy [29,30] and high-risk procedures include colonoscopy
with polypectomy and the dilatation of either benign or malignant colonic strictures (guide‐
lines extrapolated in part from experience reported in the upper gastrointestinal endoscopy lit‐
erature)  [31-33].  A comprehensive review of  the types  of  antithrombotic  therapies,  their
implications for patients undergoing colonoscopy, and recommendations and a management
Colonoscopy and Colorectal Cancer Screening - Future Directions202
algorithm for such patients using these agents has recently been published [34]. Newer antico‐
agulants, for which current guidelines regarding their being held for endoscopic procedures,
are lacking and these agents are reaching the market at an increasing rate. They include dana‐
paroid, a low molecular weight heparinoid consisting of a mixture of heparin sulfate, derma‐
tan sulfate, and chondroitin sulfate [35,36] which was recently removed from the US market
due to shortages; the direct thrombin inhibitors recombinant hirudin (lepirudin), argatroban,
desirudin and bivalirudin [37-39]; the recently available orally active direct thrombin inhibi‐
tor dabigatran etexlate [40]; and the factor Xa inhibitors idraparinux, rivaroxaban, and apixa‐
ban [41]. There is no doubt that as these agents are used they will affect practice standards with
regard to colonoscopy and polypectomy.
Acute postpolypectomy bleeding is often immediately localizable by or apparent on colono‐
scopy and amenable to endoscopic therapy using clips, ligatures, cautery or argon plasma
coagulation [42,43] or nonendoscopic techniques such as angiographic embolizaton or sur‐
gery [44]. Recent endoscopic clip application devices have undergone redesign and im‐
provements to optimize their clinical effectiveness [45]. The site of delayed postpolypectomy
colonic hemorrhage can be identified by colonoscopy, by red cell nuclear scintigraphy
and/or by selective angiography [46] and dealt with in a similar fashion.
A variety of procedural techniques have been proposed to minimize the risk of hemorrhage
complicating polypectomy. These include the avoidance of the use of the “hot biopsy” tech‐
nique [47], the use of clips or detachable snares [48,49] and possibly the use of epinephrine
injections to the base of the polyp prior to initiating the polypectomy [50,51]. Proper techni‐
que for the removal of pendunculated polyps includes planning for the application of pres‐
sure by regrasping the pedicle with the snare if immediate bleeding occurs, the injection of
epinephrine 1:10,000 to 1:20,000 dilution into the bleeding site, the application of cautery
(with thermal probes, bipolar cautery [BICAP], the argon plasma coagulator, or the tip of the
polypectomy snare), the use of hemoclips, and/or the use of loops and band ligators on the
pedicle. Similar techniques may be used in those with delayed bleeding who seem to be ac‐
tively bleeding. Up to 50 percent of patients with delayed hemorrhage may require blood
transfusion [23].
4. Colonic perforation associated with polypectomy
Perforation of the colon is the most dreaded complication of colonoscopy and polypectomy
and this risk, albeit small, should be cited in the process of obtaining informed consent form
the patient for the procedure.
Abdominal pain, abdominal distention, +/- abdominal tenderness, hiccoughs, loss of bowel
sounds indicative of ileus, and late developing peritoneal signs are the hallmarks of perfora‐
tion following colonoscopy. As physical examination, chest x-ray and abdominal flat and
upright x-ray alone or in combination may not be diagnostic of colonic perforation patients
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suspected of having this complication should undergo CT scanning of the abdomen and pel‐
vis [52]. The rate of perforation after colonoscopy ranges from 0.1-0.3% [19] and may be in‐
creased (along with the risk of hemorrhage) in those physicians who have a low procedure
volume [53]. It has been suggested that physicians who have a high perforation rate should
be evaluated for inappropriate colonoscopy practice technique [54].
Perforation risk for polypectomy may be minimized by proper technique. One should avoid
ensnaring colonic folds, particularly when the anatomy is obscured by large penduculated
or sessile lesions. By not properly lifting an ensnare polyp into the lumen of the colon before
applying current, there may be spread of thermal injury to the deeper layers of the bowel
wall increasing the risk of delayed perforation. Likewise, a pedunculated polyp should not
be resected close to the bowel wall. Care should be taken to leave some residual stalk. The
polypectomy snare should be tightly closed before applying coagulation in order to avoid
the tip of the snare behind the polyp from touching the bowel wall.
Endoscopic mucosal resection for the piecemeal removal of benign appearing sessile colonic
adenomas has become routine. Endoscopic submucosal dissection is a resection technique
applied to early gastrointestinal cancers. Complications rates are higher with endoscopic
submucosal dissection than with endoscopic mucosal resection with perforations occurring
in up to 10 percent of patients. Often these perforations can be managed by endoscopic clip‐
ping and conservative therapy, however surgery is still required in some cases and pro‐
longed hospital stays are common. [55-57].
All patients found to have evidence of colonic perforation following colonoscopy should be
seen in surgical consultation because perforation often requires surgical repair which in
some cases may be accomplished using a laparoscopic technique with avoidance of divert‐
ing colostomy formation [58,59]. It has been reported that nonsurgical management may be
appropriate for some individuals [60,61] but these patients should still undergo surgical
consultation and close monitoring for signs of deterioration. Successful endoscopic repair of
an iatrogenic colonic perforation occurring during diagnostic colonoscopy has been reported
[62] and the efficacy of a new Over-the Scope-Clip (OTSC-Ovesco Endoscopy AG, Tübingen,
Germany) device (a bear trap-like, large clip with a wingspan of 12 mms. that grasps much
more tissue than the small endoscopic clips used previously and can create a full-thickness
closure of perforations up to 3 cms. in diameter) in treating acute perforation of the gastroin‐
testinal tract has been reported [63].
5. Miscellaneous complications of colonoscopy with and without
polypectomy
5.1. Abdominal discomfort
Commonly reported but minor complications of colonoscopy include bloating and abdomi‐
nal discomfort and or pain [64-66]. The incidence of these complications may be reduced by
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avoiding “looping” of the colonoscope, avoiding excess traction applied to the bowel mes‐
entery, adequately removing insufflated gas, using carbon dioxide instead of insufflated air
[67] and by using a water insufflation technique instead of the insufflation of gas [68].
5.2. Postpolypectomy electrocoagulation syndrome
Postpolypectomy electrocagulation syndrome refers to a transmural burn and localized per‐
itonitis occurring up to a few days after the removal of a polyp without clinical or radio‐
graphic evidence of perforation of the viscus. Patients may present with localized abdominal
pain, fever, and leukocytosis. Inpatient [69] and outpatient [70] therapy have both proven to
be successful in treatment of this complication.
5.3. Infection
Transient bacteremia after colonoscopy with polypectomy is rare and signs and symptoms
of infection are even rarer [71,72]. Current guidelines exist generally advocating against an‐
tibiotic prophylaxis for those undergoing colonoscopy with or without polypectomy [73].
As these represent only guidelines it is best for the endoscopist to consult with the patient
and the referring physician before deciding to forego the use of antibiotic prophylaxis in
certain clinical situations (prosthetic heart valve, history of endocarditis, newly placed pros‐
thetic joint, etc.). Both diverticulitis [74] and appendicitis [75] the latter possibly due to bar‐
otrauma  have  been  reported  complicating  colonoscopy  done  with  and  without
polypectomy. These clinical possibilities must be kept in mind in patients with post-proce‐
dure abdominal pain.
5.4. Rare complications
Rare complications of colonoscopy with and without polypectomy have been reported and
include infections related to instrument cleanliness [76] incarceration of the colonoscope in
an inguinal hernia [77], splenic injury during colonoscopy [78], and intracolonic gas explo‐
sion during colonoscopic polypectomy [79,80]. CT colonography, the alternative to colono‐
scopy in many patients, however, is not without its own complications and adverse events
[81].
6. Conclusion
It is incumbent upon physicians performing colonoscopy to stay current in their field, keep
abreast of the medical literature and the ongoing technological advances associated with
endoscopic equipment and technique, and to be meticulous in their approach to detail in
caring for their patients, particularly when gastrointestinal endoscopic diagnostic and ther‐
apeutic procedures are involved.




♥Obtain informed consent from the patient prior to the colonoscopy procedure with emphasis on the risks of,
benefits of and alternatives to the proposed procedure
♥Be cognizant of your limitations as an endoscopist
♥Be certain that all necessary equipment to perform the colonoscopy procedure (diagnostic and therapeutic) is
available and in working order
SEDATION RELATED COMPLICATIONS
♥Perform and document a medical history and physical examination prior to the initiation of the procedure. Include
a review of the patient’s current medications, known allergies, past experiences with anesthesia, Mallampati score
and ASA Physical Status Classification
♥Ensure that the patient is properly monitored during the procedure including blood pressure, pulse, oximetry,
capnography monitoring if available, cardiac rhythm monitoring, and airway management. If working with an
anesthesiologist thoroughly discuss with your colleague the patient’s medical history and the goals of the
procedure. Maintain a dialogue with the anesthesiologist throughout the procedure
♥Ensure that tracheal intubation and cardiac defibrillation equipment as well as resuscitation medications are
available and have up to date certification in Advanced Cardiac Life Support
COLONIC HEMORRHAGE ASSOCIATED WITH POLYPECTOMY
♥Take a history of the patient’s anticoagulant use, antiplatelet agent use, and past history of bleeding diathesis if
any
♥Be thoroughly familiar with proper snare electrocautery polypectomy technique including the use of saline or
epinephrine injection into the base of the polyp before initiating electrocautery
♥Avoid the use of the “hot biopsy” technique for small (several millimeter) polyps
♥Have available for use if necessary clips, ligatures, epinephrine, a bipolar electrocautery device and/or an argon
plasma coagulation device or heater probe
♥Give specific written post-procedure instructions to the patient regarding the use of anticoagulants and
antiplatelet agents
COLONIC PERFORATION ASSOCIATED WITH POLYPECTOMY
♥Cite the risk of colonic perforation when obtaining informed consent
♥Avoid ensnaring colonic folds
♥Do not perform polypectomy when the anatomy is obscured by the size or shape of the lesion or the adequacy of
the preparation
♥Have training and familiarity with endoscopic clipping techniques
♥Have a predetermined “game plan” to expeditiously evaluate a patient suspected of having a perforation
MISCELLANEOUS COMPLICATIONS OF COLONOSCOPY WITH AND WITHOUT POLYPECTOMY
♥If available, use carbon dioxide for colonic insufflation
♥Monitor the degree of abdominal distension by palpation throughout the procedure
♥Examine the patient in the recovery area post procedure to ensure that there has been adequate evacuation of
colonic gas
♥Be cognizant of and practice infection control measures routinely
♥Keep abreast of the medical literature and ongoing technological advances associated with endoscopic
equipment and technique
Table 1. Recommendations to prevent specific colonoscopy complications
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